Eye problems linked to popular diabetes and weight loss drugs
Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while taking widely used diabetes and weight loss drugs. The medications in question—semaglutide and tirzepatide—are the active ingredients in Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound.
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
They may be the window to the soul, but researchers have found the eyes also give an insight into the brain that could help ...
including retinal vascular and diabetic eye diseases, geographic atrophy, and autoimmune conditions, such as thyroid eye disease and uveitic macular edema. Applying our extensive experience ...
Its pipeline includes innovative treatments across different modalities, such as antibodies, and gene and cell therapies targeting multiple vision-threatening conditions, including retinal vascular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback